These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8739605)

  • 1. Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor.
    Turpin JA; Schaeffer CA; Bu M; Graham L; Buckheit RW; Clanton D; Rice WG
    Antiviral Res; 1996 Mar; 29(2-3):269-77. PubMed ID: 8739605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.
    Shugars DC; Sauls DL; Weinberg JB
    Oral Dis; 1997 May; 3 Suppl 1():S70-2. PubMed ID: 9456661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.
    Wahl SM; McNeely TB; Janoff EN; Shugars D; Worley P; Tucker C; Orenstein JM
    Oral Dis; 1997 May; 3 Suppl 1():S64-9. PubMed ID: 9456660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor (SLPI): oxidation of SLPI does not explain its variable anti-HIV activity.
    Konopka K; Shine N; Pretzer E; Düzgüneş N
    J Dent Res; 1999 Dec; 78(12):1773-6. PubMed ID: 10598905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein.
    Shine NR; Wang SC; Konopka K; Burks EA; Düzgüneş N; Whitman CP
    Bioorg Chem; 2002 Aug; 30(4):249-63. PubMed ID: 12392704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.
    Hocini H; Becquart P; Bouhlal H; Adle-Biassette H; Kazatchkine MD; Bélec L
    Clin Diagn Lab Immunol; 2000 May; 7(3):515-8. PubMed ID: 10799472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
    Tomee JF; Koëter GH; Hiemstra PS; Kauffman HF
    Thorax; 1998 Feb; 53(2):114-6. PubMed ID: 9624296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine-associated serine protease inhibitors stimulate deoxyribonucleic acid synthesis in porcine endometrial glandular epithelial cells of pregnancy.
    Badinga L; Michel FJ; Simmen RC
    Biol Reprod; 1999 Aug; 61(2):380-7. PubMed ID: 10411515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of HIV Replication in Monocyte-Derived Macrophages (MDM) by Host Antiviral Factors Secretory Leukocyte Protease Inhibitor and Serpin Family C Member 1 Induced by Steroid Hormones.
    Biswas S; Chen E; Gao Y; Lee S; Hewlett I; Devadas K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
    Draper D; Donohoe W; Mortimer L; Heine RP
    J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor.
    Zhu J; Nathan C; Ding A
    Biochim Biophys Acta; 1999 Sep; 1451(2-3):219-23. PubMed ID: 10556576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
    Westin U; Lundberg E; Ohlsson K
    Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.